p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389

被引:247
作者
Huang, CS
Ma, WY
Maxiner, A
Sun, Y
Dong, ZG
机构
[1] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
[2] Parke Davis Pharmaceut Res, Dept Biol Mol, Ann Arbor, MI 48105 USA
关键词
D O I
10.1074/jbc.274.18.12229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein is a transcription factor that plays a key role in the process of apoptosis and the cell's defense against tumor development. Activation of p53 occurs, at least in part, by phosphorylation of its protein. Very recently it has been reported that UV induced a functional activation of p53 via phosphorylation at serine 389. Here, we report that the UV-induced phosphorylation of p53 at serine 389 is mediated by p38 kinase. WC-induced phosphorylation of p53 at serine 389 was markedly impaired by either pretreatment of cells with p38 kinase inhibitor, SB202190, or stable expression of a dominant negative mutant of p38 kinase. In contrast, there was no inhibition observed in cells treated with specific MEK1 inhibitor, PD98059, or with stable expression of a dominant negative mutant of ERK2 or JNK1. Most importantly, p38 kinase could be co-immunoprecipitated with p53 by using antibodies against p53. Incubation of active p38 kinase with p53 protein caused the phosphorylation of p53 protein at serine 389 in. vitro, while no phosphorylation of p53 at serine 389 was observed when p53 was incubated with activated JNK2 or ERK2. Furthermore, pretreatment of cells with SB202190 blocked the p53 DNA binding activity and p53-dependent transcription. These results strongly suggest that the p38 kinase is at least one of the most important mediators of p53 phosphorylation at serine 389 induced by UVC radiation.
引用
收藏
页码:12229 / 12235
页数:7
相关论文
共 48 条
[1]  
ADLER V, 1995, CELL GROWTH DIFFER, V6, P1437
[2]   Conformation-dependent phosphorylation of p53 [J].
Adler, V ;
Pincus, MR ;
Minamoto, T ;
Fuchs, SY ;
Bluth, MJ ;
BrandtRauf, PW ;
Friedman, FK ;
Robinson, RC ;
Chen, JM ;
Wang, XW ;
Harris, CC ;
Ronai, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1686-1691
[3]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[4]  
APPEL K, 1995, ONCOGENE, V11, P1971
[5]   Sequential DNA damage-independent and -dependent activation of NF-κB by UV [J].
Bender, K ;
Göttlicher, M ;
Whiteside, S ;
Rahmsdorf, HJ ;
Herrlich, P .
EMBO JOURNAL, 1998, 17 (17) :5170-5181
[6]   Characterization of a putative p53 binding site in the promoter of the mouse tissue inhibitor of metalloproteinases-3 (TIMP-3) gene: TIMP-3 is not a p53 target gene [J].
Bian, JH ;
Jacobs, C ;
Wang, YL ;
Sun, Y .
CARCINOGENESIS, 1996, 17 (12) :2559-2562
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]   MEKK1/JNK signaling stabilizes and activates p53 [J].
Fuchs, SY ;
Adler, V ;
Pincus, MR ;
Ronai, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10541-10546
[9]   BIOCHEMICAL-PROPERTIES AND BIOLOGICAL EFFECTS OF P53 [J].
HAFFNER, R ;
OREN, M .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (01) :84-90
[10]   Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies [J].
Harris, CC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1442-1455